SXTP
Price:
$2.22
Market Cap:
$3.27M
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
Industry
Biotechnology
IPO Date
2023-07-12
Stock Exchange
NASDAQ
Ticker
SXTP
According to 60 Degrees Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.12. This represents a change of -100.52% compared to the average of 23.23 of the last 4 quarters.
The mean historical PE Ratio of 60 Degrees Pharmaceuticals, Inc. over the last ten years is -248.87. The current -0.12 PE Ratio has changed -95.18% with respect to the historical average. Over the past ten years (40 quarters), SXTP's PE Ratio was at its highest in in the March 2024 quarter at 95.96. The PE Ratio was at its lowest in in the March 2022 quarter at -428.57.
Average
-248.87
Median
-262.63
Minimum
-535.16
Maximum
-0.37
Discovering the peaks and valleys of 60 Degrees Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.37
Minimum Annual Increase = -99.43%
Minimum Annual PE Ratio = -535.16
Year | PE Ratio | Change |
---|---|---|
2024 | -0.37 | -99.43% |
2023 | -64.36 | -75.49% |
2022 | -262.63 | -31.22% |
2021 | -381.85 | -28.65% |
The current PE Ratio of 60 Degrees Pharmaceuticals, Inc. (SXTP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-109.12
5-year avg
-248.87
10-year avg
-248.87
60 Degrees Pharmaceuticals, Inc.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 60 Degrees Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 60 Degrees Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is 60 Degrees Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for 60 Degrees Pharmaceuticals, Inc. (SXTP)?
What is the highest PE Ratio for 60 Degrees Pharmaceuticals, Inc. (SXTP)?
What is the 3-year average PE Ratio for 60 Degrees Pharmaceuticals, Inc. (SXTP)?
What is the 5-year average PE Ratio for 60 Degrees Pharmaceuticals, Inc. (SXTP)?
How does the current PE Ratio for 60 Degrees Pharmaceuticals, Inc. (SXTP) compare to its historical average?